SMARCE1-related meningiomas: A clear example of cancer predisposing syndrome.


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 19 12 2022
revised: 23 04 2023
accepted: 06 05 2023
medline: 5 6 2023
pubmed: 11 5 2023
entrez: 10 5 2023
Statut: ppublish

Résumé

We report the case of a 16-year-old girl presenting with spinal clear-cell multiple meningiomas (CCMs). In view of this presentation, we sequenced a bioinformatic panel of genes associated with susceptibility to meningioma, identifying a germline heterozygous variant in SMARCE1. Somatic DNA investigations in the CCM demonstrated the deletion of the wild-type allele (loss of heterozygosity, LOH), supporting the causative role of this variant. Family segregation study detected the SMARCE1 variant in the asymptomatic father and in the asymptomatic sister who, nevertheless, presents 2 spinal lesions. Germline heterozygous loss-of-function (LoF) variants in SMARCE1, encoding a protein of the chromatin-remodeling complex SWI/SNF, have been described in few familial cases of susceptibility to meningioma, in particular the CCM subtype. Our case confirms the role of NGS in investigating predisposing genes for meningiomas (multiple or recurrent), with specific regard to SMARCE1 in case of pediatric CCM. In addition to the age of onset, the presence of familial clustering or the coexistence of multiple synchronous meningiomas also supports the role of a genetic predisposition that deserves a molecular assessment. Additionally, given the incomplete penetrance, it is of great importance to follow a specific screening or follow-up program for symptomatic and asymptomatic carriers of pathogenic variants in SMARCE1.

Identifiants

pubmed: 37164167
pii: S1769-7212(23)00090-3
doi: 10.1016/j.ejmg.2023.104784
pii:
doi:

Substances chimiques

Chromosomal Proteins, Non-Histone 0
DNA-Binding Proteins 0
SMARCE1 protein, human 0
Transcription Factors 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104784

Informations de copyright

Copyright © 2023 Elsevier Masson SAS. All rights reserved.

Auteurs

Erika Fiorentini (E)

Medical Genetics Unit, Department of Clinical and Experimental Biomedical Sciences 'Mario Serio', University of Florence, Firenze, Italy. Electronic address: erika.fiorentini@unifi.it.

Laura Giunti (L)

Neuro-Oncology Unit, Department of Pediatric Oncology, Meyer Children's Hospital, Firenze, Italy.

Andrea Di Rita (A)

Division of Neurosurgery - Meyer Children's Hospital - University of Florence, Firenze, Italy.

Simone Peraio (S)

Division of Neurosurgery - Meyer Children's Hospital - University of Florence, Firenze, Italy.

Carla Fonte (C)

Neuro-Oncology Unit, Department of Pediatric Oncology, Meyer Children's Hospital, Firenze, Italy.

Chiara Caporalini (C)

Pathology Unit, A. Meyer Children's University Hospital, Firenze, Italy.

Anna Maria Buccoliero (AM)

Pathology Unit, A. Meyer Children's University Hospital, Firenze, Italy.

Maria Luigia Censullo (ML)

Neuro-Oncology Unit, Department of Pediatric Oncology, Meyer Children's Hospital, Firenze, Italy.

Giulia Gori (G)

Medical Genetics Unit, Meyer Children's University Hospital, Firenze, Italy.

Alice Noris (A)

Division of Neurosurgery - Meyer Children's Hospital - University of Florence, Firenze, Italy.

Rosa Pasquariello (R)

Dpt. of Neuroscience, IRCCS Fondazione Stella Maris, Calambrone, Pisa, Italy.

Roberta Battini (R)

Dpt. of Neuroscience, IRCCS Fondazione Stella Maris, Calambrone, Pisa, Italy; Dpt. of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Rossana Pavone (R)

Neuro-Oncology Unit, Department of Pediatric Oncology, Meyer Children's Hospital, Firenze, Italy.

Flavio Giordano (F)

Division of Neurosurgery - Meyer Children's Hospital - University of Florence, Firenze, Italy.

Sabrina Giglio (S)

Medical Genetics Unit, Department of Medical Sciences and Public Health and CeSAR, University Service for Research, University of Cagliari, 09124, Cagliari, Italy.

Berardo Rinaldi (B)

Medical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH